Beyond the assay: why diagnostic device development needs three separate specifications
Beyond the Assay: Why Diagnostic Device Development Needs Three Separate SpecificationsWritten by Paul Edmondson - Director - eg t
Clear terminology, faster clinical device development
In this article, we explore what ‘clinical trial device’ really means, why consistent terminology is crucial to a shared understanding of the stage of development, and how this links to what regulators expect before approving a clinical investigation.
De-risking development with off-the-shelf modules
Off‑the‑shelf electronics modules are often more expensive and are sometimes assumed to be complex or not an exact fit for specific requirements, yet these perceptions often overlook the real advantages they bring.
Why Human Factors Will Drive Business Growth in 2026
When was the last time you abandoned a product because it was frustrating to use? When products are frustrating to use, users will abandon them, share their discontent or fail to adopt them in the first place.
How AI is transforming surgical decision support
Artificial intelligence is emerging as one of the most influential forces reshaping modern surgical practice.
Designing hybrid user interfaces: Bridging the physical and digital
As devices become increasingly complex and connected, user interfaces are being relied upon to bridge the gap between the physical and digital parts of a system. This often leads to hybrid interfaces, a blend of physical controls and digital displays.
CES 2026: Human-centred innovation takes the stage
This year at CES, many companies focused on something we at eg technology care deeply about - designing products that genuinely support people. Ambient AI working quietly in the background, robotics designed around real tasks, calmer smart homes and wearables that reduce cognitive load all featured strongly. This blog look at the key outcomes from the show and unveils AI's shifting role in…
J.P. Morgan 2026: How MedTech leaders are de-risking product development
What’s shaping MedTech product development in 2026? At this year’s J.P. Morgan Healthcare Conference, one message was clear: growth now depends on how effectively teams de‑risk product development. From intentional AI integration to stronger execution strategies and a sharper investor focus, MedTech leaders are prioritising predictable delivery over ambitious promises. In this blog, eg…
Will my medical device software fail?
By eg technologyIn recent years, there has been increasing acceptance that ‘bug-free software’ is and has always been a myth.
Digital health: route to market
By eg technology's Head of Software, Stephen StarkieIn this, the second of a two-part series, Stephen addresses some of the things you should think about for Digital Health products on your route to market...
Mbed OS: The article we wish we had read
By eg technology's Head of Software, Stephen StarkieHere we talk in depth about the company's journey to using Arm Mbed OS and the Pelion client in medical devices. There is a lot of technical detail here, which will help people at the sharp end and will give you a flavour of what to expect, but if you are interested in our overall opinion, feel free to skip to the conclusion!
What is Digital Health?
By eg technology's Group Lead of Software, Stephen StarkieStephen delves in to some of the confusion around Digital Health to describe what it is and how to approach it...
Case studies - an important part of the development pathway
By eg technologyCase studies. A very dry, unengaging term describing the very life blood of your business – actual, contextual examples of your expertise. They really should have a more engaging name!